[Increased risk after sudden discontinuation of beta receptor blockader therapy?].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D002395:Catecholamines / Q000378:metabolism; D003000:Clonidine / Q000008:administration & dosage; D006801:Humans; D005996:Nitroglycerin / Q000008:administration & dosage; D011433:Propranolol / Q000008:administration & dosage; D012306:Risk; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011433:Propranolol; D005996:Nitroglycerin; D003000:Clonidine
Erhöhtes Risiko nach abruptem Absetzen von Beta-Rezeptorenblockern?